PharmacoEconomics & Outcomes News 792, p9 - 2 Dec 2017 Costs of diabetes-related absenteeism high in USA Costs of diabetes-related healthcare and absenteeism are high in USA, reported Mary Caffrey from the American Journal of Managed Care (AJMC) Managed Markets Network. In a report released for World Diabetes Day, an analysis of data from 135 000 interviews in 50 US states for the Gallup-Sharecare Wellbeing Index found that diabetes mellitus was associated with a total of $425.5 billion in healthcare costs and $20.4 billion in employer costs due to absenteeism in 2017. According to the Cost of Diabetes in the U.S.: Economic and Well- Being Impact report, the incidence of diabetes in US adults in 2017 was 11.5% overall, 6.3% in full-time workers and 9.1% in part-time workers. Compared with the general population, full-time and part-time workers with diabetes missed an additional 5.5 and 4.3 workdays per year, respectively. Nationally, employers lost 58 million more work days in employees with diabetes than in employees without diabetes. At $354 per lost work day, employer costs due to absenteeism totalled $16 billion and $4.4 billion for full-time and part-time workers, respectively. "As these very large companies have become self- insured, they see the benefit of keeping people healthier longer to mitigate the risk of prediabetes, and eventually diabetes," commented Sheila Holcomb, vice president of Sharecare Diabetes Solution. Sharecare’s Blue Zones initiative has shown that communities with low rates of diabetes also have lower rates of heart disease, obesity and smoking, increased levels of exercise, and increased access to healthcare. "If you can slow down the progression—or stop the progression—of type 2 diabetes, that’s not only good for the employers, it’s good for the employees as well," said Holcombe. Caffrey M. Healthcare, Absenteeism Costs of Diabetes Reach $266B in US Internet Document : 14 Nov 2017. Available from: URL: http://www.ajmc.com/ newsroom/healthcare-absenteeism-costs-of-diabetes-reach-266b-in-us 803284218 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792
PharmacoEconomics & Outcomes News – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera